Directory Search Results
£80,495,720
Total Funding
Extending the applicability of Therakind’s previously developed single use intranasal dry powder parenteral administration system for use with a wider range of drugs. The newly extended role of the ...
Children with severe speech impairments are often provided with communication aids to compose messages spoken using synthesised speech. However, communication aids can be slow and tiring to use. They ...
Tika is developing innovative reagents for improving rapid diagnosis of mycobacterial infections. Tika has discovered and optimised the use of a new supplement that in a laboratory setting can sign...
TwistDX has developed a 15-minute point of care test for Chlamydia/Gonorrhoea. This enables diagnosis and treatment within one clinic visit, bringing significant clinical advantages of increased tr...
Ubisense technology accurately locates the position of tagged items within an indoor environment, monitoring interactions between these objects and utilising the information to drive software appli...
Ubisense technology accurately locates the position of tagged items within an indoor environment, monitoring interactions between these objects and utilising the information to drive software appli...
A novel automation of Cognitive Restructuring (CR) that will revolutionise mobile-delivered Cognitive Therapy. For the first time ever, this automation of CR will allow patients to receive therapeutic...
Ulsys is developing a wearable solution to significantly enhance and monitor the treatment of venous leg ulcers, enabling pro-active management, patient participation and more efficient use of outp...
Venous leg ulcers are the most common chronic wounds in the Western World. They can be very painful, take a long time to heal (sometimes years) and recurrences are common.Treating them often involves ...
uMotif is developing a mobile software application to deliver structured support for young people and young adults who are self-harming or are at risk of self-harm.
« Previous Page — Next Page »
